tetano
Editor, Senior Moderator
Vaccine. 2020 Jan 10. pii: S0264-410X(19)31720-7. doi: 10.1016/j.vaccine.2019.12.056. [Epub ahead of print] [h=1]The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis.[/h]
Jarvis JR[SUP]1[/SUP], Dorey RB[SUP]2[/SUP], Warricker FDM[SUP]3[/SUP], Alwan NA[SUP]4[/SUP], Jones CE[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] To determine the effectiveness of influenza vaccination during pregnancy on child health outcomes.
[h=4]DESIGN:[/h] Systematic review/meta-analysis.
[h=4]DATA SOURCES:[/h] Clinical Trials.gov, Cochrane Library, EMBASE, Medline, Medline in process, PubMed and Web of Science, from 1st January 1996 to 29th June 2018. An updated Medline search was performed 30th June 2018 to 31st October 2019.
[h=4]METHODS:[/h] Randomised controlled trials (RCTs) and observational studies reporting health outcomes of infants and children born to women who received inactivated influenza vaccine during pregnancy. The primary outcome was infant laboratory confirmed influenza (LCI). Secondary outcomes included influenza-like illness (ILI), other respiratory illnesses, primary care, clinic visit or hospitalisations due to influenza illness and long-term respiratory childhood outcomes.
[h=4]RESULTS:[/h] 19 studies were included; 15 observational studies and 4 primary RCTs with an additional 3 papers reporting secondary outcomes of these RCTs. In a random effects meta-analysis of 2 RCTs including 5742 participants, maternal influenza vaccination was associated with an overall reduction of LCI in infants of 34% (95% confidence interval 15-50%). However, there was no effect of maternal influenza vaccination on ILI in infants ≤6 months old. Two RCTs were excluded from the meta-analysis for the outcome of LCI in infants (different controls used). Both of these studies showed a protective effect for infants from LCI, with a vaccine efficacy of up to a 70%. Overall observational studies showed an inverse (protective) association between maternal influenza vaccination and infant LCI, hospitalisation and clinic visits due to LCI or ILI in infants and other respiratory illness in infants ≤6 months old.
[h=4]CONCLUSIONS:[/h] This systematic review supports maternal influenza vaccination as a strategy to reduce LCI and influenza-related hospitalisations in young infants. Communicating these benefits to pregnant women may support their decision to accept influenza vaccination in pregnancy and increase vaccine coverage in pregnant women.
[h=4]REGISTRATION:[/h] PROSPERO CRD42018102776.
Copyright ? 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
[h=4]KEYWORDS:[/h] Children; Immunisation; Infant; Influenza; Influenza-like illness; Maternal; Meta-analysis; Pregnancy; Systematic review; Vaccine
PMID: 31932138 DOI: 10.1016/j.vaccine.2019.12.056
Jarvis JR[SUP]1[/SUP], Dorey RB[SUP]2[/SUP], Warricker FDM[SUP]3[/SUP], Alwan NA[SUP]4[/SUP], Jones CE[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] To determine the effectiveness of influenza vaccination during pregnancy on child health outcomes.
[h=4]DESIGN:[/h] Systematic review/meta-analysis.
[h=4]DATA SOURCES:[/h] Clinical Trials.gov, Cochrane Library, EMBASE, Medline, Medline in process, PubMed and Web of Science, from 1st January 1996 to 29th June 2018. An updated Medline search was performed 30th June 2018 to 31st October 2019.
[h=4]METHODS:[/h] Randomised controlled trials (RCTs) and observational studies reporting health outcomes of infants and children born to women who received inactivated influenza vaccine during pregnancy. The primary outcome was infant laboratory confirmed influenza (LCI). Secondary outcomes included influenza-like illness (ILI), other respiratory illnesses, primary care, clinic visit or hospitalisations due to influenza illness and long-term respiratory childhood outcomes.
[h=4]RESULTS:[/h] 19 studies were included; 15 observational studies and 4 primary RCTs with an additional 3 papers reporting secondary outcomes of these RCTs. In a random effects meta-analysis of 2 RCTs including 5742 participants, maternal influenza vaccination was associated with an overall reduction of LCI in infants of 34% (95% confidence interval 15-50%). However, there was no effect of maternal influenza vaccination on ILI in infants ≤6 months old. Two RCTs were excluded from the meta-analysis for the outcome of LCI in infants (different controls used). Both of these studies showed a protective effect for infants from LCI, with a vaccine efficacy of up to a 70%. Overall observational studies showed an inverse (protective) association between maternal influenza vaccination and infant LCI, hospitalisation and clinic visits due to LCI or ILI in infants and other respiratory illness in infants ≤6 months old.
[h=4]CONCLUSIONS:[/h] This systematic review supports maternal influenza vaccination as a strategy to reduce LCI and influenza-related hospitalisations in young infants. Communicating these benefits to pregnant women may support their decision to accept influenza vaccination in pregnancy and increase vaccine coverage in pregnant women.
[h=4]REGISTRATION:[/h] PROSPERO CRD42018102776.
Copyright ? 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
[h=4]KEYWORDS:[/h] Children; Immunisation; Infant; Influenza; Influenza-like illness; Maternal; Meta-analysis; Pregnancy; Systematic review; Vaccine
PMID: 31932138 DOI: 10.1016/j.vaccine.2019.12.056